M&A Deal Summary

Clarivate Acquires Decision Resources Group

On January 17, 2020, Clarivate acquired information technology company Decision Resources Group from Piramal Enterprises for 950M USD

Acquisition Highlights
  • This is Clarivate’s 3rd transaction in the Information Technology sector.
  • This is Clarivate’s 2nd largest (disclosed) transaction.
  • This is Clarivate’s 3rd transaction in the United States.
  • This is Clarivate’s 1st transaction in Massachusetts.

M&A Deal Summary
Date 2020-01-17
Target Decision Resources Group
Sector Information Technology
Buyer(s) Clarivate
Sellers(s) Piramal Enterprises
Deal Type Divestiture
Deal Value 950M USD

Target

Decision Resources Group

Burlington, Massachusetts, United States
Decision Resources Group (DRG) is a premier provider of high-value data, analytics and insights products, and services to the healthcare industry. DRG helps clients propel commercial success with evidence-based business decisions by delivering expert consultation, data, and analysis enhanced by machine learning artificial intelligence (AI). With collaborative experts spanning healthcare markets, disease areas, and data science disciplines, DRG clients have unprecedented access to the expertise, data, and AI-technology solutions they require to anticipate customer needs and generate new solutions to healthcare challenges.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Clarivate

London, United Kingdom
Category Company
Founded 1864
Sector Information Services
Employees12,000
Revenue 2.6B USD (2023)
DESCRIPTION

Clarivate is a provider of solutions to accelerate the lifecycle of innovation. Clarivate bold mission is to help customers solve some of the world's most complex problems by providing actionable information and insights that reduce the time from new ideas to life-changing inventions in the areas of science and intellectual property. We help customers discover, protect, and commercialize their inventions using our trusted subscription and technology-based solutions coupled with deep domain expertise. Clarivate was founded in 1864 and is based in London, United Kingdom.

DEAL STATS #
Overall 6 of 14
Sector (Information Technology) 3 of 4
Type (Divestiture) 2 of 2
State (Massachusetts) 1 of 1
Country (United States) 3 of 7
Year (2020) 1 of 3
Size (of disclosed) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-12-02 Darts-IP SPRL

Brussels, Belgium

Darts-IP SPRL is a provider of case law data and analytics for intellectual property (IP) professionals. Darts-IP is based in Brussels, Belgium.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-07-29 CPA Global

Jersey, Channel Islands

CPA Global is an intellectual property (IP) management and technology company serving over 10,000 customers and connecting millions of global IP users every day. CPA Global was founded in 1969 and is based in Jersey, Channel Islands.

Buy -

Seller(S) 1

SELLER

Piramal Enterprises

Mumbai, India
Category Company
Founded 1947
Sector Healthcare Services
Employees3,000
Revenue 81.1B INR (2024)
DESCRIPTION

Piramal Enterprises is a diversified Indian conglomerate. Piramal Group operates healthcare, drug discovery and research, glass, real estate and financial services. Piramal Enterprises was founded in 1947 and is based in Mumbai, India.

DEAL STATS #
Overall 3 of 3
Sector (Information Technology) 1 of 1
Type (Divestiture) 2 of 2
State (Massachusetts) 1 of 1
Country (United States) 1 of 1
Year (2020) 1 of 1
Size (of disclosed) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-01-30 Mallinckrodt - Intrathecal Therapy Business

Dublin, Ireland

Mallinckrodt plc - Intrathecal Therapy Business includes Gablofen® (baclofen), a severe spasticity management product, which is currently marketed in the United States, and two pain management products, which are currently under development.

Buy $171M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-03-31 Hemmo Pharmaceutical

Mumbai, India

Hemmo Pharmaceutical develops and manufactures peptide APIs. Its portfolio covers 30+ APIs including generic peptides, peptide NCEs and peptides in clinical development which it offers to pharma and research companies in both domestic and global markets. Hemmo Pharmaceutical was founded in 1979 and is based in Mumbai, India.

Buy -
Mergr

Product

Company

Legal